Angiopoietin-1 is essential in mouse vasculature during development and in response to injury. - Test2 - elhamkhani - TriplyDB

Angiopoietin-1 is essential in mouse vasculature during development and in response to injury.

Angiopoietin-1 is essential in mouse vasculature during development and in response to injury.

http://www.wikidata.org/entity/Q24629743

about

Angiopoietins and diabetic nephropathy The pericyte: a forgotten cell type with important implications for Alzheimer's disease?Fibrinogen-Related Proteins in Tissue Repair: How a Unique Domain with a Common Structure Controls Diverse Aspects of Wound Healing Signaling pathways in the development of infantile hemangioma Receptor tyrosine kinase-mediated angiogenesis Molecular mechanisms of diabetic kidney disease Molecular control of endothelial cell behaviour during blood vessel morphogenesis Emerging roles of pericytes in the regulation of the neurovascular unit in health and disease All's well that transcribes well: non-coding RNAs and post-stroke brain damage Development of the kidney medulla Glucose Starvation in Cardiomyocytes Enhances Exosome Secretion and Promotes Angiogenesis in Endothelial Cells Rapamycin improves TIE2-mutated venous malformation in murine model and human subjects Epidermal growth factor: a new therapeutic target in glomerular disease.Angiopoietin-Tie signalling in the cardiovascular and lymphatic systems Crosstalk in glomerular injury and repair A lymphatic defect causes ocular hypertension and glaucoma in mice Nitric-oxide synthase trafficking inducer is a pleiotropic regulator of endothelial cell function and signaling.Clinical therapeutic strategies for early stage of diabetic kidney disease.Development of the renal arterioles.Angiopoietin 2 mediates microvascular and hemodynamic alterations in sepsis Angiopoietin-2-induced arterial stiffness in CKD Common and specific effects of TIE2 mutations causing venous malformations Tie1 controls angiopoietin function in vascular remodeling and inflammation.Central nervous system pericytes in health and disease.Structural basis of Tie2 activation and Tie2/Tie1 heterodimerization.Plastic roles of pericytes in the blood-retinal barrier.Differentiated demographic histories and local adaptations between Sherpas and Tibetans Podocytes, signaling pathways, and vascular factors in diabetic kidney disease Angiopoietin 2 regulates the transformation and integrity of lymphatic endothelial cell junctions.Circulating endoglin concentration is not elevated in chronic kidney disease Myocardium-derived angiopoietin-1 is essential for coronary vein formation in the developing heart.VEGFR1-positive macrophages facilitate liver repair and sinusoidal reconstruction after hepatic ischemia/reperfusion injury.CCN1 and CCN2: blood brothers in angiogenic action.Design and implementation of a custom built optical projection tomography system.Endothelial destabilization by angiopoietin-2 via integrin β1 activation.Angiopoietins modulate endothelial adaptation, glomerular and podocyte hypertrophy after uninephrectomy.Glomerular endothelial cell injury and cross talk in diabetic kidney disease Id proteins regulate capillary repair and perivascular cell proliferation following ischemia-reperfusion injury PPARγ agonists improve survival and neurocognitive outcomes in experimental cerebral malaria and induce neuroprotective pathways in human malaria.SDF-1/CXCR4 signaling preserves microvascular integrity and renal function in chronic kidney disease.

P2860

Q26747192-0FAE5705-F6F0-4E34-8363-89454A08EFB1 Q26852369-62BB6FAC-1160-43F9-B347-C550FCD78D33 Q26866370-B82B3550-0C22-4400-9FD1-C39067FFB1F0 Q26996608-CAFA22AA-539A-44BE-AC55-AAFD2C507FE0 Q27001612-A55886B5-0E79-488E-9532-4832655127F9 Q27003963-C6CF0A1D-F7A3-45C4-81D2-0B17ED235436 Q27007664-B5A086CB-29CC-4B21-B144-1E1E20F89CCB Q27011505-1FFEECD2-3991-4435-B002-80942395A9B0 Q27012757-D04E3192-9F40-4B06-AD2D-E5FB266CCDA0 Q27015938-FB79A97C-CBF7-416A-A750-5DD336BAA4C3 Q27316713-B70782ED-BD3B-493A-AE6B-9E4313568698 Q27333126-54416DE1-43F7-42D5-8335-DE25A047384A Q27686898-AC9129A1-8357-408A-8B9C-04F8C9C4BDC7 Q28070234-A9AD179C-571A-4C41-AF7F-4564BAE538E9 Q28085092-45C27DAD-8CA5-45AB-BA75-CC72BE98EFA8 Q28247543-40FA765D-35B0-4C06-9116-8B46805998E6 Q30008769-3834D881-FA53-475F-B81E-CB7892F615ED Q30363683-A8E4FB03-96C3-4784-B0E2-65F2C6A942F1 Q30423671-B194DF9D-FA18-43FB-9656-728EEF028593 Q30541878-B861634A-ECEF-4263-B2D7-B9CA6DE0BCC2 Q30578820-B042ABF5-CE9F-4CAD-9F2C-366CAF352A7B Q30670028-C0D02451-7244-4201-875A-40536F37ACF2 Q30805233-3FA1D57B-0FD6-406F-BC4C-40BED38E64A0 Q33609398-40190E0A-3D8E-42C3-915A-280CEEA389D1 Q33620110-F836F6C1-50E9-4FB6-B413-938EB95991DC Q33716453-A501D91B-943A-436A-B07D-455EC8FE93C9 Q33805296-4BCEB839-7BB9-43F4-869F-EE90692BBAE4 Q33821237-84C90562-31AF-430C-B4C6-2D86B732E593 Q33917453-EA27EBAC-C478-45FB-A911-8E5100E3C25B Q34008908-93E08C78-F779-494A-A17B-81B28BA6C622 Q34014661-EE704F35-B2EB-47C3-9CFD-47F62002E23A Q34097471-4AEA1F65-A952-4A8F-945B-FD843EF09018 Q34352095-2EB6C9EE-24FD-4FA0-85C3-37B6E5C9009B Q34984458-2FDC250A-129B-4C1C-97D1-C7AED7E8B540 Q35047913-1C021EE2-EDC0-4C79-80D4-7941D9887AA3 Q35075339-F4285384-37E2-4968-B0FF-79DC923523B7 Q35086477-CCEA3F07-20A3-4E7C-8759-32D4A7A82D29 Q35091758-57B6EAB2-3692-47B9-B390-9550E20B7F50 Q35113069-25E443CF-95BE-404C-A3D0-940BB5ACC8B2 Q35123087-8FE9F666-0115-460D-B500-951D601F59DE

P2860

Angiopoietin-1 is essential in mouse vasculature during development and in response to injury.

http://www.wikidata.org/entity/Q24629743

description

2011 nî lūn-bûn

@nan

2011 թուականի Մայիսին հրատարակուած գիտական յօդուած

@hyw

2011 թվականի մայիսին հրատարակված գիտական հոդված

@hy

2011年の論文

@ja

2011年論文

@yue

2011年論文

@zh-hant

2011年論文

@zh-hk

2011年論文

@zh-mo

2011年論文

@zh-tw

2011年论文

@wuu

name

Angiopoietin-1 is essential in ...... ment and in response to injury

@nl

Angiopoietin-1 is essential in ...... ent and in response to injury.

@ast

Angiopoietin-1 is essential in ...... ent and in response to injury.

@en

type

label

Angiopoietin-1 is essential in ...... ment and in response to injury

@nl

Angiopoietin-1 is essential in ...... ent and in response to injury.

@ast

Angiopoietin-1 is essential in ...... ent and in response to injury.

@en

prefLabel

Angiopoietin-1 is essential in ...... ment and in response to injury

@nl

Angiopoietin-1 is essential in ...... ent and in response to injury.

@ast

Angiopoietin-1 is essential in ...... ent and in response to injury.

@en

P1433

Q24629743-56111310-27E0-43D2-90CE-16F917B463F8

P1476

Q24629743-3B78574C-E0EC-4A5B-9A2B-2E235D9CBE65

P2093

Q24629743-2E52761C-B5D2-4036-AA12-4E62B96A03F9

Q24629743-7CADBEF2-B130-43F7-8441-3D47A77141D8

Q24629743-9DBDCE85-ECB1-46BF-91C5-F979EA57C9E6

Q24629743-C4D7ED83-5848-4072-A17C-3F01E959BED3

Q24629743-CA3E761B-3C8B-4381-96F3-01E31EDE5412

Q24629743-FA241D83-47CB-4D83-81BA-52F1422D4F96

P2860

Q24629743-02498A36-72E1-48AF-9A59-6E205BF721EA

Q24629743-1CEA5236-DBA4-4E77-8B2D-D585B7078F78

Q24629743-235ED57F-5190-41C6-8777-FBECD6BC0AF4

Q24629743-26274F4B-CD77-4F78-BE90-135BC8686E31

Q24629743-269FFADE-021E-4FC1-8D6A-C6F43E8C019F

Q24629743-2A650C81-4252-4416-9110-896C4F005CC0

Q24629743-2D778437-2D04-4E2F-8353-D9C153E21DCD

Q24629743-2DA9BE98-B712-4443-8028-12EE65EBCF8D

Q24629743-2F877EE8-6D55-464E-BED4-EDD6EA43A98E

Q24629743-503420AF-E305-4D88-9ABE-E2C60ABC6E1C

P304

Q24629743-9313A65C-E380-49AA-8370-608A727F68BE

P31

Q24629743-B92B9719-47DA-47B6-BA22-DE84E1F11651

P3181

Q24629743-802D85DE-7CC2-4023-A1E0-7727AEDA7CC9

P356

Q24629743-B84A74BE-5E6B-42CA-98C5-31D36D8122C2

P407

Q24629743-5F9763A7-970C-490B-A22E-D619D29F1C4B

P433

Q24629743-1D6B1CE3-A3A3-412E-8BCC-68C6C96FEAFB

P478

Q24629743-FDDE29B4-D309-4B0A-9722-691A9B89BB42

P50

Q24629743-36FC6028-3961-4E94-9709-B87D8BFFB4A1

P577

Q24629743-132CAF51-C458-4E4D-B81F-F4CF89B2D510

P698

Q24629743-A560572E-9B34-45A0-90E5-317E4C380835

P932

Q24629743-89FE7910-51D6-45B4-9B8F-84D4EF554D6E

P3181

P356

P1433

Journal of Clinical Investigation

P1476

Angiopoietin-1 is essential in ...... ent and in response to injury.

@en

P2093

Alexander Gawlik

http://www.w3.org/2001/XMLSchema#string

Chengjin Li

http://www.w3.org/2001/XMLSchema#string

Gregory Anderson

http://www.w3.org/2001/XMLSchema#string

Marie Jeansson

http://www.w3.org/2001/XMLSchema#string

Mark Henkelman

http://www.w3.org/2001/XMLSchema#string

Susan E Quaggin

http://www.w3.org/2001/XMLSchema#string

P2860

Three-dimensional analysis of vascular development in the mouse embryo

Vascular dysmorphogenesis caused by an activating mutation in the receptor tyrosine kinase TIE2

Angiopoietin 1 and vascular endothelial growth factor modulate human glomerular endothelial cell barrier properties

VEGF inhibition and renal thrombotic microangiopathy

Cre recombinase: the universal reagent for genome tailoring

Plasma vascular endothelial growth factor, angiopoietin-1, and angiopoietin-2 in diabetes: implications for cardiovascular risk and effects of multifactorial intervention

Requisite role of angiopoietin-1, a ligand for the TIE2 receptor, during embryonic angiogenesis

Leakage-resistant blood vessels in mice transgenically overexpressing angiopoietin-1

A highly efficient recombineering-based method for generating conditional knockout mutations

Pericytes regulate the blood-brain barrier

P304

2278-2289

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P3181

1471372

http://www.w3.org/2001/XMLSchema#string

P356

10.1172/JCI46322

http://www.w3.org/2001/XMLSchema#string

P407

P433

6

http://www.w3.org/2001/XMLSchema#string

P478

121

http://www.w3.org/2001/XMLSchema#string

P50

Dontscho Kerjaschki

P577

2011-05-23T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

21606590

http://www.w3.org/2001/XMLSchema#string

P932

3104773

http://www.w3.org/2001/XMLSchema#string